WallStreetZenWallStreetZen

NASDAQ: CKPT
Checkpoint Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CKPT

Based on 2 analysts offering 12 month price targets for Checkpoint Therapeutics Inc.
Min Forecast
$4.00+181.69%
Avg Forecast
$19.00+1,238.03%
Max Forecast
$34.00+2,294.37%

Should I buy or sell CKPT stock?

Based on 2 analysts offering ratings for Checkpoint Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CKPT stock forecasts and price targets.

CKPT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-22
lockedlocked$00.00+00.00%2023-12-20

1 of 1

Forecast return on equity

Is CKPT forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is CKPT forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CKPT revenue forecast

What is CKPT's revenue in the next 1 years based on estimates from 2 analysts?
Avg 1 year Forecast
$635.0k+516.5%
CKPT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CKPT revenue growth forecast

How is CKPT forecast to perform vs Biotechnology companies and vs the US market?
Company
1,423.38%
Industry
37.04%
Market
9.92%
CKPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CKPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CKPT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CKPT$1.42$19.00+1,238.03%Strong Buy
ABIO$3.48N/AN/A
ELDN$2.02$13.00+543.56%Buy
GANX$3.07$8.00+160.59%Strong Buy
GNTA$2.91N/AN/A
View Top Biotech Stocks

Checkpoint Therapeutics Stock Forecast FAQ

Is Checkpoint Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CKPT) stock is to Strong Buy CKPT stock.

Out of 2 analysts, 1 (50%) are recommending CKPT as a Strong Buy, 1 (50%) are recommending CKPT as a Buy, 0 (0%) are recommending CKPT as a Hold, 0 (0%) are recommending CKPT as a Sell, and 0 (0%) are recommending CKPT as a Strong Sell.

If you're new to stock investing, here's how to buy Checkpoint Therapeutics stock.

What is CKPT's revenue growth forecast for 2024-2024?

(NASDAQ: CKPT) Checkpoint Therapeutics's forecast annual revenue growth rate of 1,423.38% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Checkpoint Therapeutics's revenue in 2024 is $103,000.

In 2024, CKPT is forecast to generate $22,660,787 in revenue, with the lowest revenue forecast at $3,568,628 and the highest revenue forecast at $41,752,946.

What is CKPT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CKPT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CKPT's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CKPT price target, the average CKPT price target is $19.00, with the highest CKPT stock price forecast at $34.00 and the lowest CKPT stock price forecast at $4.00.

On average, Wall Street analysts predict that Checkpoint Therapeutics's share price could reach $19.00 by Mar 22, 2025. The average Checkpoint Therapeutics stock price prediction forecasts a potential upside of 1,238.03% from the current CKPT share price of $1.42.

What is CKPT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CKPT) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.